Social anxiety nasal spray safety trial ends early
NCT ID NCT05030350
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested the safety of a nasal spray called PH94B for people with social anxiety disorder. Participants used the spray up to 4 times a day for up to 12 months when feeling anxious. The trial was terminated early, so we don't have full results on its safety or effectiveness.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
PH94B nasal spray
What this could lead to
If successful, this could point toward a fast-acting, on-demand treatment for anxiety in social situations.
What could go wrong
The trial was terminated early, so results are incomplete. It is unclear if PH94B is safe or effective long-term.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOCIAL ANXIETY DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
VistaGen Investigational Site
Watertown, Massachusetts, 02472, United States
-
VistaGen Investigational Site
New York, New York, 10128, United States
-
VistaGen Investigational Site
Bellevue, Washington, 98007, United States